Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

19952,436 citationsJournal Article

Authors

Thierry Philip · Centre Léon Bérard

Cesare Guglielmi · Sapienza University of Rome

Anton Hagenbeek · Rotterdam University of Applied Sciences

Renier Somers · The Netherlands Cancer Institute

Hans van der Lelie · Academic Medical Center

Dominique Bron · Institut Jules Bordet

Pieter Sonneveld

Abstract

As compared with conventional chemotherapy, treatment with high-dose chemotherapy and autologous bone marrow transplantation increases event-free and overall survival in patients with chemotherapy-sensitive non-Hodgkin's lymphoma in relapse.

Topics & Keywords

Lymphoma Diagnosis and Treatment Viral-associated cancers and disorders Chronic Lymphocytic Leukemia Research

Publication Details

Published in: New England Journal of Medicine

Volume 333, Issue 23, pp. 1540-1545

DOI: 10.1056/nejm199512073332305

Field-Weighted Citation Impact: 34.06

Command Palette

Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

Authors

Abstract

Topics & Keywords

Publication Details